FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

J&J Files BLA for Myasthenia Gravis Therapy

Johnson & Johnson files a BLA for nipocalimab, indicated for treating people living with generalized myasthenia gravis.

Animal Drugs

FDA Publishes 2 Revised VICH Guidances

FDA publishes two revised Veterinary International Conference on Harmonization guidances on validation of analytical procedures for veterinary drugs.

Human Drugs

FDA Clears Thinks Robitic System for 2 Knee Implants

FDA clears a Think Surgical 510(k) for the TMini Miniature Robotic System and its use with the GMK Sphere and SpheriKA Knee Systems from Medacta Inter...

latest-news-card-1
Human Drugs

Merck Discontinues 2 Keytruda Phase 3 Trials

Merck says that on the recommendation of independent data monitoring committees, it is discontinuing a Keytruda lung cancer trial and a cutaneous squa...

latest-news-card-1
Medical Devices

Tandem Updates Apple Mobile Diabetes Pump App

Tandem Diabetes Care says it is recalling an Apple app used with its t:slim insulin pump and replacing it with updated software.

latest-news-card-1
Human Drugs

CDER Creates Internal AI Council

CDER creates a new internal Artificial Intelligence Council to oversee, coordinate, and consolidate all Center AI activities.

latest-news-card-1
Human Drugs

Nuvectis Gets Orphan Status for NXP800

FDA grants Nuvectis Pharma an orphan drug designation for NXP800 and its use in treating ovarian, fallopian tube, and primary peritoneal cancers.

latest-news-card-1
Medical Devices

Renata Expandable Growth Stent OKd for Infants

FDA approves a Renata Medical PMA for its Minima Growth Stent thats intended for treating congenital heart disease in infants and young children.

latest-news-card-1
Federal Register

Exelas Fentanyl Not Withdraw Over Safety/Efficacy

Federal Register notice: FDA determines that Exela Pharma Sciences fentanyl citrate injections, equivalent to 2.5mg/50mL and 5mg/100mL (EQ 0.05 mg bas...

latest-news-card-1
Federal Register

Mirum Pharma Wins Priority Review Voucher

Federal Register notice: FDA announces that it issued Mirum Pharmaceuticals a priority review voucher for its approved rare pediatric disease product ...